Decreased levels of TIMP‐3 have been shown in various human malignancies including breast cancer, prostate cancer, gastric cancer, esophageal squamous cell carcinoma, endometrial cancer, and cholangiocarcinomas.12, 13, 14, 15, 16. This evidence concerns the gene TIMP3 and endometrial cancer.